Live Breaking News & Updates on Japan Sosei Group Corp
Stay updated with breaking news from Japan sosei group corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tech Transfer Roundup: Tiba And CEPI Strategize Together On 'Disease X' :: Scrip informa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from informa.com Daily Mail and Mail on Sunday newspapers.
Tech Transfer Roundup: Norway's Tiba And CEPI Strategize Together On 'Disease X' :: Scrip informa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from informa.com Daily Mail and Mail on Sunday newspapers.
(2) LONDON (dpa-AFX) - Japan s Sosei Group Corp said that it has reached a global collaboration and license agreement with GlaxoSmithKline Plc (GSK.L, GSK) targeting immune disorders of the digestive system in a deal worth up to $481 million. Sosei said the agreement will focus on the discovery and development of selective, oral, small molecule agonists of GPR35, an important orphan G protein-coupled receptor (GPCR) with genetic association to inflammatory bowel disease (IBD) and other gastrointestinal immune disorders. As per the deal, GSK licenses global rights to a portfolio of GPR35 agonists designed by Sosei Heptares using its StaR technology and structure-based drug design platform. The licensed portfolio includes an advanced lead preclinical compound as well as multiple differentiated back-up compounds. ....
Sosei, GSK agree to develop inflammatory bowel disease treatment katcountry989.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from katcountry989.com Daily Mail and Mail on Sunday newspapers.